The epidermal growth factor receptor: A missing link between endoplasmic reticulum stress and diabetic complications?

Hypertension

Volumn 60, Issue 1, 2012, Pages 20-21

  Kobayashi, Tomonori ^a   Eguchi, Satoru ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; METALLOPROTEINASE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; ANIMAL; HEART; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASODILATATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; ENDOPLASMIC RETICULUM STRESS; HEART; MALE; RECEPTOR, EPIDERMAL GROWTH FACTOR; VASODILATION;

EID: 84865805428     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.197038     Document Type: Note

References (10)

1. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008;454:455-462.
2. Minamino T, Komuro I, Kitakaze M. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ Res. 2010;107:1071-1082.
3. Scheuner D, Kaufman RJ. The unfolded protein response: a pathway that links insulin demand with β-cell failure and diabetes. Endocr Rev. 2008;29:317-333.
4. Ohtsu H, Dempsey PJ, Frank GD, Brailoiu E, Higuchi S, Suzuki H, Nakashima H, Eguchi K, Eguchi S. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II. Arterioscler Thromb Vasc Biol. 2006;26:e133-e137.
5. Takaguri A, Kimura K, Hinoki A, Bourne AM, Autieri MV, Eguchi S. A disintegrin and metalloprotease 17 mediates neointimal hyperplasia in vasculature. Hypertension. 2011;57:841-845.
6. Chen J, Chen JK, Nagai K, Plieth D, Tan M, Lee TC, Threadgill DW, Neilson EG, Harris RC. EGFR signaling promotes TGFβ-dependent renal fibrosis. J Am Soc Nephrol. 2012;23:215-224.
7. Prada PO, Ropelle ER, Mourao RH, De Souza CT, Pauli JR, Cintra DE, Schenka A, Rocco SA, Rittner R, Franchini KG, Vassallo J, Velloso LA, Carvalheira JB, Saad MJ. EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice. Diabetes. 2009;58:2910-2919.
8. Serino M, Menghini R, Fiorentino L, Amoruso R, Mauriello A, Lauro D, Sbraccia P, Hribal ML, Lauro R, Federici M. Mice heterozygous for tumor necrosis factor-α converting enzyme are protected from obesityinduced insulin resistance and diabetes. Diabetes. 2007;56:2541-2546.
9. Galán M, Kassan M, Choi S-K, Partyka M, Trebak M, Henrion D, Matrougui K. A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus. Hypertension. 2012;60:71-80.
10. Uttarwar L, Peng F, Wu D, Kumar S, Gao B, Ingram AJ, Krepinsky JC. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells. Am J Physiol Renal Physiol. 2011;300:F921-F931.